Is MindBio Therapeutics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, MindBio Therapeutics Corp (MBIO.CN) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is MindBio Therapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MindBio Therapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of MindBio Therapeutics Corp?

Muslim investors may consider investing in MindBio Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is MindBio Therapeutics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of MindBio Therapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for MindBio Therapeutics Corp updated?

The Shariah compliance status of MindBio Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like MindBio Therapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of MindBio Therapeutics Corp?

You can check the latest Shariah compliance status of MindBio Therapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MBIO.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: December 19, 2025

Report Source: 2026 1st Quarter Report

MindBio Therapeutics Corp. Stock Analysis MBIO.CN

Canada N/A Nano Cap Report: Q1, 2026

MindBio Therapeutics Corp. engages in the development of psychedelic substances for mental health conditions. The company creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. The company is focused on microdosing of psychedelic medicines and is advancing its drug and technology through clinical trials. The company develops a multidisciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase I clinical trials in 80 healthy participants and has completed Phase II clinical trials in patients with Major Depressive Disorder. Underway are Phase IIB trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. The company invests in research that forms the basis for developing novel and clinically proven treatments.

Key Statistics of MindBio Therapeutics Corp (MBIO.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.90CAD0.92

Today's Open

CAD0.92

Volume

43.27K

P/E Ratio (TTM)

52 Week Range

CAD0.50CAD6.00

Market Cap

5.51M

Avg. Volume

27.73K

Dividend Yield

Financial Metrics & Statements of MindBio Therapeutics Corp (MBIO.CN)

FAQ's for MindBio Therapeutics Corp (MBIO.CN)

According to Musaffa’s Shariah screening methodology, MindBio Therapeutics Corp (MBIO.CN) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.